Bartlett J C, Tuzcu E M, Simpfendorfer C, Dorosti K, Franco I, Whitlow P
Department of Cardiology, Cleveland Clinic Foundation, OH 44195.
J Invasive Cardiol. 1991 Mar-Apr;3(2):62-5.
We analyzed the immediate and long-term outcome of percutaneous transluminal angioplasty (PTCA) of native coronary arteries via saphenous vein grafts (SVG) in 30 patients. The mean age of the grafts was 69 months. Angioplasty was successful in 27 (90%) patients. One patient died following emergency bypass surgery. There were no distal embolizations and one non-Q myocardial infarction. Follow-up angiography was performed in 12 patients, which revealed restenosis in three patients. At a mean follow-up of 20 months, cumulative survival was 93%. Freedom from myocardial infarction, repeat bypass surgery, and death was 80%. We conclude that PTCA of native coronary arteries via SVG is a safe alternative to repeat CABG in selected patients.
我们分析了30例经大隐静脉移植血管(SVG)对自身冠状动脉进行经皮腔内血管成形术(PTCA)的近期和长期结果。移植血管的平均使用时间为69个月。27例(90%)患者血管成形术成功。1例患者在急诊搭桥手术后死亡。无远端栓塞发生,1例非Q波心肌梗死。12例患者接受了随访血管造影,其中3例显示有再狭窄。平均随访20个月时,累积生存率为93%。无心肌梗死、再次搭桥手术和死亡的生存率为80%。我们得出结论,对于部分患者,经SVG对自身冠状动脉进行PTCA是再次冠状动脉旁路移植术(CABG)的安全替代方案。